Editorial: Advances in the treatment of hormonal receptor positive (HR+) breast cancer by Wala Ben Kridis, Zheng Wang, Deniz Can Guven, Arunasalam Dharmarajan

Get full text

Gleason score and docetaxel response in advanced hormone-sensitive prostate cancer: The lower the better by Omer Dizdar, Deniz Can Guven, Gurkan Guner, Mustafa Erman, Mutlu Hayran

Get full text

Learning From Failure: Negative Trials in Oncology by Mirella Nardo, Deniz Can Guven, Aysun Senturk Yikilmaz, Shambhavi Singh, Jibran Ahmed

Get full text

Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer by Francesca Matilde Schipilliti, Denise Drittone, Federica Mazzuca, Daniele La Forgia, Deniz Can Guven, Alessandro Rizzo

Get full text

Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine by Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy

Get full text

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges by Deniz Can Guven, Taha Koray Sahin, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Kazim Sahin

Get full text

Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19 by Deniz Can Guven, Taha Koray Sahin, Oktay Halit Aktepe, Hasan Cagri Yildirim, Sercan Aksoy, Saadettin Kilickap

Get full text

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis by Deniz Can Guven, Taha Koray Sahin, Enes Erul, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Suayib Yalcin

Get full text

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine by Riccardo Carloni, Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, Raffaele De Luca, Deniz Can Guven, Suayib Yalcin, Giovanni Brandi

Get full text

Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis by Elsa Vitale, Alessandro Rizzo, Lorenza Maistrello, Deniz Can Guven, Raffaella Massafra, Veronica Mollica, Fernando Sabino Marques Monteiro, Matteo Santoni, Francesco Massari

Get full text

Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation by Enes Ucgul MD, Deniz Can Guven MD, Aybala Nur Ucgul MD, Yakup Ozbay MD, Mehmet Ruhi Onur MD, Serkan Akin MD

Get full text

Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab by Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, Ece Karaca, Yunus Kaygusuz, Omer Dizdar, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Saadettin Kilickap

Get full text

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer by Feride Yılmaz, Serkan Yaşar, Ömer Denizhan Tatar, Hasan Çağrı Yıldırım, Deniz Can Güven, Arif Akyıldız, Elvin Chalabiyev, Burak Yasin Aktaş, Zafer Arık, Mustafa Erman

Get full text

Monitoring Over Time of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Through an Ensemble Vision Transformers‐Based Model by Maria Colomba Comes, Annarita Fanizzi, Samantha Bove, Luca Boldrini, Agnese Latorre, Deniz Can Guven, Serena Iacovelli, Tiziana Talienti, Alessandro Rizzo, Francesco Alfredo Zito, Raffaella Massafra

Get full text

Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab by Hasan Cagri Yildirim, Hicran Anik, Deniz Ates Ozdemir, Rashad Ismayilov, Arif Akyildiz, Kerim Cayiroz, Fahri Ceyhan, Oguzalp Kavruk, Deniz Can Guven, Ozturk Ates, Alp Usubutun, Zafer Arik

Get full text

Investigating the WNT and TGF-beta pathways alterations and tumor mutation burden in young-onset colorectal cancer by Morgan Ferrell, Deniz Can Guven, Cyndi Gonzalez Gomez, Elham Nasrollahi, Richard Giza, Svea Cheng, Masood Pasha Syed, Tara Magge, Aatur Singhi, Anwaar Saeed, Turcin Saridogan, Ibrahim Halil Sahin

Get full text

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia by Burak Yasin Aktaş, Emine Büşra Ata, Engin Çeşmeci, İbrahim Yahya Çakır, Muharrem Coşkunpınar, Yağmur Tahillioğlu, Gürkan Güner, Deniz Can Güven, Zafer Arık, Neyran Kertmen, Ömer Dizdar, Şuayib Yalçın, Sercan Aksoy

Get full text

Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrence by Annarita Fanizzi, Federico Fadda, Maria Colomba Comes, Samantha Bove, Annamaria Catino, Erika Di Benedetto, Angelo Milella, Michele Montrone, Annalisa Nardone, Clara Soranno, Alessandro Rizzo, Deniz Can Guven, Domenico Galetta, Raffaella Massafra

Get full text

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study by Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap

Get full text

Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinica... by Çağlar Ünal, Çetin Ordu, Tolga Özmen, Ahmet Serkan İlgun, Filiz Çelebi, Bülent Baysal, Enver Özkurt, Tomris Duymaz, Zeynep Erdoğan İyigün, Sevgi Kurt, Mehmet Alper Öztürk, Kezban Nur Pilancı, Gül Alço, Kanay Yararbaş, Tuba Kayan Tapan, Deniz Can Güven, Gürsel Soybir, Vahit Özmen

Get full text